| Integrating network pharmacology and pharmacological evaluation for deciphering the action mechanism of herbal formula zuojin pill in suppressing hepatocellular carcinoma W Guo, J Huang, N Wang, HY Tan, F Cheung, F Chen, Y Feng Frontiers in Pharmacology 10, 1185, 2019 | 188 | 2019 |
| Herbal medicine in the treatment of non-alcoholic fatty liver diseases-efficacy, action mechanism, and clinical application Y Xu, W Guo, C Zhang, F Chen, HY Tan, S Li, N Wang, Y Feng Frontiers in Pharmacology 11, 601, 2020 | 126 | 2020 |
| microRNA-23a in human cancer: its roles, mechanisms and therapeutic relevance N Wang, HY Tan, YG Feng, C Zhang, F Chen, Y Feng Cancers 11 (1), 7, 2018 | 98 | 2018 |
| Immunomodulatory potential of natural products from herbal medicines as immune checkpoints inhibitors: Helping to fight against cancer via multiple targets Z Zhong, CT Vong, F Chen, H Tan, C Zhang, N Wang, L Cui, Y Wang, ... Medicinal Research Reviews 42 (3), 1246-1279, 2022 | 75 | 2022 |
| Direct inhibition of the TLR4/MyD88 pathway by geniposide suppresses HIF‐1α‐independent VEGF expression and angiogenesis in hepatocellular carcinoma C Zhang, N Wang, HY Tan, W Guo, F Chen, Z Zhong, K Man, SW Tsao, ... British Journal of Pharmacology 177 (14), 3240-3257, 2020 | 67 | 2020 |
| The impacts of herbal medicines and natural products on regulating the hepatic lipid metabolism S Li, Y Xu, W Guo, F Chen, C Zhang, HY Tan, N Wang, Y Feng Frontiers in Pharmacology 11, 351, 2020 | 57 | 2020 |
| Targeting cancer metabolism to resensitize chemotherapy: potential development of cancer chemosensitizers from traditional Chinese medicines W Guo, HY Tan, F Chen, N Wang, Y Feng Cancers 12 (2), 404, 2020 | 55 | 2020 |
| The functional roles of exosomes-derived long non-coding RNA in human cancer F Chen, N Wang, HY Tan, W Guo, C Zhang, Y Feng Cancer biology & therapy 20 (5), 583-592, 2019 | 49 | 2019 |
| Suppression of lncRNA MALAT1 by betulinic acid inhibits hepatocellular carcinoma progression by targeting IAPs via miR‐22‐3p F Chen, Z Zhong, HY Tan, W Guo, C Zhang, CS Cheng, N Wang, J Ren, ... Clinical and translational medicine 10 (6), e190, 2020 | 48 | 2020 |
| PIWIL1 governs the crosstalk of cancer cell metabolism and immunosuppressive microenvironment in hepatocellular carcinoma N Wang, HY Tan, Y Lu, YT Chan, D Wang, W Guo, Y Xu, C Zhang, F Chen, ... Signal Transduction and Targeted Therapy 6 (1), 86, 2021 | 46 | 2021 |
| Interpreting the pharmacological mechanisms of huachansu capsules on hepatocellular carcinoma through combining network pharmacology and experimental evaluation J Huang, F Chen, Z Zhong, HY Tan, N Wang, Y Liu, X Fang, T Yang, ... Frontiers in Pharmacology 11, 414, 2020 | 40 | 2020 |
| Immune checkpoint B7-H3 is a therapeutic vulnerability in prostate cancer harboring PTEN and TP53 deficiencies W Shi, Y Wang, Y Zhao, JJ Kim, H Li, C Meng, F Chen, J Zhang, DH Mak, ... Science translational medicine 15 (695), eadf6724, 2023 | 33 | 2023 |
| ID1 overexpression increases gefitinib sensitivity in non-small cell lung cancer by activating RIP3/MLKL-dependent necroptosis HY Tan, N Wang, YT Chan, C Zhang, W Guo, F Chen, Z Zhong, S Li, ... Cancer Letters 475, 109-118, 2020 | 30 | 2020 |
| The Significance of circulating tumor cells in patients with hepatocellular carcinoma: real-time monitoring and moving targets for cancer therapy F Chen, Z Zhong, HY Tan, N Wang, Y Feng Cancers 12 (7), 1734, 2020 | 26 | 2020 |
| Uncovering the anticancer mechanisms of Chinese herbal medicine formulas: therapeutic alternatives for liver cancer F Chen, Z Zhong, HY Tan, W Guo, C Zhang, C Tan, S Li, N Wang, Y Feng Frontiers in Pharmacology 11, 293, 2020 | 25 | 2020 |
| The Underlying Mechanisms of Chinese Herbal Medicine-Induced Apoptotic Cell Death in Human Cancer F Chen, Z Zhong, HY Tan, N Wang, Y Feng Programmed Cell Death, 2019 | 4 | 2019 |
| Exploring the anti-hepatocellular carcinoma effects of Xianglian Pill: integrating network pharmacology and RNA sequencing via in silico and in vitro studies J Huang, R Shi, F Chen, HY Tan, J Zheng, N Wang, R Li, Y Wang, T Yang, ... Phytomedicine 133, 155905, 2024 | 2 | 2024 |
| Potential Focal Adhesion Kinase Inhibitors in Management of Cancer: Therapeutic Opportunities from Herbal Medicine F Chen, Z Zhong, C Zhang, Y Lu, YT Chan, N Wang, D Zhao, Y Feng International journal of molecular sciences 23 (21), 13334, 2022 | 2 | 2022 |
| What Chinese Medicine Can Do for Liver Cancer? F Chen, N Wang, Y Feng Liver Cancer, 2018 | 1 | 2018 |
